Monsenso signs contract with the Norwegian University of Science & Technology

Monsenso signs contract with the Norwegian University of Science & Technology

Monsenso has signed a contract with the Norwegian University of Science & Technology to use Monsenso’s digital health solution to collect sensor data in a research project aiming at improving relapse prevention with substance use disorders.

The research study aims to improve the prediction of relapse using mobile sensing to identify a digital phenotype approach to relapse prevention. The research project is led by Anders Lauvsnes, Department of Mental Health, Faculty of Medicine and Health Sciences, at the Norwegian University of Science & Technology and covers up to 100 research participants with substance use disorders.

Mobile sensing, the use of passive data generated by personal electronic devices such as smartphones and wearables to measure human functioning, has generated considerable research interest over the past years. Particularly in the field of mental health, where the collection of continuous and objective data can lead to clinically useful biomarkers to support the prevention, early intervention, and treatment of a variety of conditions, including addiction.

“Addiction and substance use disorders are major health challenges worldwide, and relapse is a core component of addictive disorders. The dynamics surrounding relapse, and particularly the immediate period leading up to it, are only partially understood, due in large part to the difficulty of collecting reliable and sufficient data from this narrow period,” says Anders Lauvsnes. “Mobile sensing offers the opportunity to identify predictive patterns of relapse by accurately mapping behaviour. Together with data on symptoms worsening, it can help us identify a digital phenotype for relapse prevention”.

The Monsenso digital solution will be used to remotely monitor study participants, collecting sensor data from mobile phones along with sensor data from wearables (Whitings). After completion of the data collection, the data will be analysed along with neurocognitive measures using machine learning to predict imminent relapse to substance use and describe individual and temporal variability in risk.

“We are very excited to contribute to this project of creating a digital phenotype to help reduce relapse,” said Thomas Lethenborg, CEO of Monsenso. “Mobile sensing does indeed offer a data-driven method to improve condition monitoring for actionable outcomes, such as early signs of relapse, thereby ensuring the right individuals receive the right treatment at the right time”.

About Monsenso digital health solution:
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer

Mental health affects all aspects of our life. ​Yet, it’s the most neglected area

Mental health affects all aspects of our life. ​Yet, it’s the most neglected area

Mental health affects all aspects of our life. ​Yet, it’s the most neglected area of public health, driving higher risk of comorbid disorders and mortality. 

​’Mental health’ as a term refers to cognitive, behavioral, and emotional well-being. It is all about how we think, feel, and behave. The state of your mental health determines how you handle stress, how you relate to others, and how you make healthy choices. As such, mental health affects all aspects of daily living, relationships, and physical health. For some people, “mental health” means the absence of a mental disorder. For others, it equals a life with daily stressors, mood disorders, affecting their ability to function.

Close to 1 billion people globally are living with a mental disorder[1]. In fact, mental disorder affects one in four families – a number which is expected to rise significantly over the next 20 years [2]. As measured by ’years of life lived with disability’, mental illness is the biggest disease burden in society today[3].

Without doubt, mental health is an important topic. Yet, the magnitude and burden of mental disorders remain unmet by the response. Countries across the globe have long overlooked the issue of mental health and mental illness. As such, more than 33% of countries allocate less than 1% of the total health budgets to mental health, with another 33% of countries spending just 1% of their budgets on mental health[4]. Consequently, relatively few people around the world have access to quality mental health services. In low- and middle-income countries, more than 75% of people with mental, neurological and substance use disorders receive no treatment for their condition at all [5].

If left untreated, mental illness can lead to other commodity disorders, such as depression, substance abuse and even early mortality. Substance abuse is common among people who are battling a depressive disorder, which can lead to further exacerbation of the symptoms related to depression, impairing mental functioning, and further damaging overall spirit, quality of life. Likewise, many individuals who develop substance use disorders (SUD) are also diagnosed with mental disorders, and vice versa. As such, mental health disorder patients accounts of 44% of cocaine and 38% of alcohol consumption​ [6,7]. ​

The magnitude, suffering and burden in terms of disability and costs for individuals, families and societies are staggering. Every year, the harmful use of alcohol results in millions of deaths, including hundreds of thousands of young lives lost. Illicit drug use disorders is – directly and indirectly – responsible for over 750,000 deaths per year. ​Not to mention, the 1 million people, whom commit suicide every year across the world [8].

Mental health has been hidden behind a curtain of stigma and discrimination for too long. It is time to bring it out into the open. Help us raise awareness, by sharing our post.

To learn more about how Monsenso mhealth solution can be used to increase treatment outcome, see our video below:



[1]WHO -2020

[2] WHO -2001

[3] WHO – 2012

[4] WHO – 2019 

[5] WHO – The Mental health Gab Action Programme (mhGAP)

[6], The national Bureau of Economic research – 2020

[7] The National bureau of economic research. Mental health and substance abuse. 2020.

[8] WHO – Investigating in mental health